JAZZ logo

Jazz Pharmaceuticals (JAZZ) Cash from operations

annual CFO:

$1.40B+$303.90M(+27.83%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual cash flow from operations is $1.40 billion, with the most recent change of +$303.90 million (+27.83%) on December 31, 2024.
  • During the last 3 years, JAZZ annual CFO has risen by +$617.40 million (+79.31%).
  • JAZZ annual CFO is now at all-time high.

Performance

JAZZ Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

quarterly CFO:

$429.78M+$31.20M(+7.83%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly cash flow from operations is $429.78 million, with the most recent change of +$31.20 million (+7.83%) on March 1, 2025.
  • Over the past year, JAZZ quarterly CFO has increased by +$162.56 million (+60.83%).
  • JAZZ quarterly CFO is now at all-time high.

Performance

JAZZ quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

TTM CFO:

$1.56B+$162.56M(+11.65%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ TTM cash flow from operations is $1.56 billion, with the most recent change of +$162.56 million (+11.65%) on March 1, 2025.
  • Over the past year, JAZZ TTM CFO has increased by +$519.93 million (+50.06%).
  • JAZZ TTM CFO is now at all-time high.

Performance

JAZZ TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

JAZZ Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+27.8%+60.8%+50.1%
3 y3 years+79.3%+105.7%+121.8%
5 y5 years+79.8%+57.5%+84.0%

JAZZ Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+79.3%at high+156.8%at high+121.8%
5 y5-yearat high+79.8%at high+930.8%at high+121.8%
alltimeall timeat high+1171.9%at high+1063.9%at high+1217.1%

JAZZ Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$429.78M(+7.8%)
$1.56B(+11.6%)
Dec 2024
$1.40B(+27.8%)
$398.58M(-0.0%)
$1.40B(+19.9%)
Sep 2024
-
$398.75M(+20.3%)
$1.16B(+8.5%)
Jun 2024
-
$331.35M(+24.0%)
$1.07B(+3.3%)
Mar 2024
-
$267.23M(+59.7%)
$1.04B(-4.9%)
Dec 2023
$1.09B(-14.1%)
$167.34M(-45.5%)
$1.09B(-13.8%)
Sep 2023
-
$307.19M(+3.5%)
$1.27B(-8.0%)
Jun 2023
-
$296.76M(-7.5%)
$1.38B(-0.5%)
Mar 2023
-
$320.71M(-6.2%)
$1.38B(+8.8%)
Dec 2022
$1.27B(+63.4%)
$341.97M(-18.2%)
$1.27B(+14.8%)
Sep 2022
-
$417.99M(+37.9%)
$1.11B(+14.9%)
Jun 2022
-
$303.04M(+45.0%)
$963.83M(+37.2%)
Mar 2022
-
$208.98M(+17.6%)
$702.49M(-9.8%)
Dec 2021
$778.51M(-13.5%)
$177.75M(-35.1%)
$778.51M(-1.1%)
Sep 2021
-
$274.06M(+557.3%)
$787.02M(+2.1%)
Jun 2021
-
$41.70M(-85.4%)
$770.85M(-15.4%)
Mar 2021
-
$285.00M(+53.0%)
$911.68M(+1.3%)
Dec 2020
$899.65M(+15.9%)
$186.27M(-27.8%)
$899.65M(+12.3%)
Sep 2020
-
$257.89M(+41.3%)
$801.17M(-9.0%)
Jun 2020
-
$182.52M(-33.1%)
$880.79M(+4.0%)
Mar 2020
-
$272.97M(+210.9%)
$847.12M(+9.1%)
Dec 2019
$776.40M(-2.8%)
$87.80M(-74.0%)
$776.40M(-14.4%)
Sep 2019
-
$337.50M(+126.7%)
$906.70M(+14.7%)
Jun 2019
-
$148.85M(-26.4%)
$790.67M(-5.2%)
Mar 2019
-
$202.25M(-7.3%)
$833.80M(+4.4%)
Dec 2018
$798.90M(+15.3%)
$218.10M(-1.5%)
$798.90M(+1.7%)
Sep 2018
-
$221.47M(+15.4%)
$785.37M(+4.3%)
Jun 2018
-
$191.97M(+14.7%)
$752.79M(+8.2%)
Mar 2018
-
$167.36M(-18.2%)
$695.91M(+0.4%)
Dec 2017
$693.09M(+17.0%)
$204.56M(+8.3%)
$693.09M(+3.6%)
Sep 2017
-
$188.90M(+39.8%)
$669.22M(+9.1%)
Jun 2017
-
$135.09M(-17.9%)
$613.35M(+1.3%)
Mar 2017
-
$164.54M(-8.9%)
$605.28M(+2.2%)
Dec 2016
$592.39M(+11.4%)
$180.69M(+35.8%)
$592.39M(+11.5%)
Sep 2016
-
$133.03M(+4.7%)
$531.44M(-7.3%)
Jun 2016
-
$127.01M(-16.2%)
$573.49M(-2.3%)
Mar 2016
-
$151.65M(+26.7%)
$587.04M(+10.4%)
DateAnnualQuarterlyTTM
Dec 2015
$531.94M(+30.5%)
$119.74M(-31.6%)
$531.94M(-2.7%)
Sep 2015
-
$175.08M(+24.5%)
$546.46M(+9.1%)
Jun 2015
-
$140.57M(+45.6%)
$501.08M(+15.1%)
Mar 2015
-
$96.56M(-28.1%)
$435.44M(+6.8%)
Dec 2014
$407.61M(+41.3%)
$134.26M(+3.5%)
$407.61M(+15.7%)
Sep 2014
-
$129.70M(+73.1%)
$352.38M(-0.3%)
Jun 2014
-
$74.92M(+9.0%)
$353.47M(+23.0%)
Mar 2014
-
$68.72M(-13.0%)
$287.26M(-0.4%)
Dec 2013
$288.43M(+15.5%)
$79.03M(-39.6%)
$288.43M(-8.1%)
Sep 2013
-
$130.79M(+1400.0%)
$313.74M(+38.2%)
Jun 2013
-
$8.72M(-87.5%)
$227.10M(-23.1%)
Mar 2013
-
$69.89M(-33.0%)
$295.35M(+18.3%)
Dec 2012
$249.75M(+64.7%)
$104.34M(+136.4%)
$249.75M(+32.1%)
Sep 2012
-
$44.14M(-42.6%)
$189.07M(-1.0%)
Jun 2012
-
$76.97M(+216.8%)
$190.98M(+26.1%)
Mar 2012
-
$24.30M(-44.4%)
$151.44M(-0.1%)
Dec 2011
$151.60M(+157.5%)
$43.66M(-5.2%)
$151.60M(+16.0%)
Sep 2011
-
$46.05M(+23.0%)
$130.73M(+26.7%)
Jun 2011
-
$37.44M(+53.1%)
$103.16M(+34.3%)
Mar 2011
-
$24.45M(+7.3%)
$76.82M(+30.5%)
Dec 2010
$58.87M(-470.8%)
$22.79M(+23.3%)
$58.87M(+55.5%)
Sep 2010
-
$18.49M(+66.7%)
$37.85M(+377.8%)
Jun 2010
-
$11.09M(+70.6%)
$7.92M(-287.3%)
Mar 2010
-
$6.50M(+266.8%)
-$4.23M(-73.4%)
Dec 2009
-$15.88M(-87.8%)
$1.77M(-115.5%)
-$15.88M(-56.4%)
Sep 2009
-
-$11.44M(+981.5%)
-$36.44M(-32.1%)
Jun 2009
-
-$1.06M(-79.5%)
-$53.68M(-44.8%)
Mar 2009
-
-$5.15M(-72.6%)
-$97.21M(-25.4%)
Dec 2008
-$130.23M(+60.6%)
-$18.79M(-34.5%)
-$130.23M(-6.6%)
Sep 2008
-
-$28.69M(-35.7%)
-$139.51M(+10.6%)
Jun 2008
-
-$44.59M(+16.8%)
-$126.19M(+28.3%)
Mar 2008
-
-$38.17M(+36.0%)
-$98.35M(+21.3%)
Dec 2007
-$81.09M(+41.4%)
-$28.06M(+82.6%)
-$81.09M(+52.9%)
Sep 2007
-
-$15.37M(-8.2%)
-$53.03M(+40.8%)
Jun 2007
-
-$16.75M(-19.9%)
-$37.66M(+80.1%)
Mar 2007
-
-$20.91M
-$20.91M
Dec 2006
-$57.35M(+9.9%)
-
-
Dec 2005
-$52.16M
-
-

FAQ

  • What is Jazz Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual CFO year-on-year change?
  • What is Jazz Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly CFO year-on-year change?
  • What is Jazz Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals TTM CFO year-on-year change?

What is Jazz Pharmaceuticals annual cash flow from operations?

The current annual CFO of JAZZ is $1.40B

What is the all time high annual CFO for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual cash flow from operations is $1.40B

What is Jazz Pharmaceuticals annual CFO year-on-year change?

Over the past year, JAZZ annual cash flow from operations has changed by +$303.90M (+27.83%)

What is Jazz Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of JAZZ is $429.78M

What is the all time high quarterly CFO for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly cash flow from operations is $429.78M

What is Jazz Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, JAZZ quarterly cash flow from operations has changed by +$162.56M (+60.83%)

What is Jazz Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of JAZZ is $1.56B

What is the all time high TTM CFO for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high TTM cash flow from operations is $1.56B

What is Jazz Pharmaceuticals TTM CFO year-on-year change?

Over the past year, JAZZ TTM cash flow from operations has changed by +$519.93M (+50.06%)
On this page